Medable vs Signant eCOA(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Medable

Best for
Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform
What to consider
Medable pairs a large library (400+ validated instruments, 120+ locales) with Study Studio, a no-code builder its site says takes studies live in 4 to 6 weeks. It publishes Part 11, Annex 11, HIPAA and GDPR compliance but no regulatory approval counts or prices.
Read product profile

Signant eCOA

Best for
CNS and other complex-endpoint trials that need clinician ratings, licensing support and global logistics
What to consider
Signant combines a 50+ instrument library, in-house licensing support and 50+ clinical and eCOA experts with operations in 135+ countries. It says it supported 25% of FDA and EMA novel drug approvals from 2020 to 2025 and now adds wearable sensors through Ametris. Builds are vendor-led and prices are not published.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Medable vs Signant eCOA (eCOA): category feature evidence and sources. Products are not ranked.
Category featureMedableSignant eCOA
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Supported

400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked.

Source
About this support label

A validated library is documented; licensing services are not described.

Extended support

Library of 50+ instruments, many pre-approved by authors; scale licensing and management support; 50+ clinical and eCOA experts.

Source
About this support label

The library includes author-approved instruments with scale licensing and management support.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published.

Source
Unknown

States it supported 25% of novel drug approvals across FDA and EMA in 2020-2025 (company-wide).

Source
About this support label

A company-wide approval-history claim does not establish trial or security controls.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Extended support

80+ countries and 120+ locales; device logistics from six global depots to 65+ countries.

Source
About this support label

The note documents deployment across countries and localized participant support.

Supported

Operates in 135+ countries, supports 600+ live eCOA studies and ran a BYOD study with 47,000+ participants.

Source
About this support label

Multicountry operations are documented; language support is not established by this note.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Extended support

eCOA, eConsent, TeleVisit and devices in one platform, BYOD or provisioned, with sensors and connectors to other clinical systems.

Source
About this support label

BYOD and provisioned devices are documented alongside sensors and clinical-system connectors.

Supported

Provisioned, web and BYOD deployment, ePRO and complex ClinRO, and wearable sensors through the Ametris acquisition.

Source
About this support label

BYOD, provisioned capture and wearable sensors are listed; sensor integration is not established by this note.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Supported

Study Studio is a no-code visual builder; studies that took 16 to 20 weeks go live in 4 to 6 weeks, some in a day.

Source
About this support label

A no-code builder and launch timing are documented; study-team self-service is not explicit.

Supported

Automation gives '33% faster eCOA launch timelines'; builds are delivered by Signant, no self-service eCOA designer published.

Source
About this support label

Vendor-delivered builds are described; a self-service designer is not published.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Supported

Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount.

Source
About this support label

A monthly device-provisioning model is described; platform prices are not published.

Unknown

Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only.

Source
About this support label

Sales contact alone does not establish a published pricing model, prices or contract terms.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.